APR 02, 2017 8:28 AM PDT

Liver Hormone Hides from Pneumonia Bacteria

WRITTEN BY: Kara Marker

Humans have iron in their blood just like hundreds of other organisms; iron is an essential component in many proteins, and almost all organisms need iron in some form. Unfortunately, bacteria need iron to survive just as much as humans do, and the competition for iron in the blood becomes a matter of life or death in an age where bacteria are becoming increasingly resistant to existing antibiotics.

A mouse lung infected with Klebsiella bacteria. The area of infection is located right next to a blood vessel (in the middle filled with red cells), where the bacteria can enter the bloodstream and spread throughout the body. Credit: Kathryn Michels

All kinds of bacteria causing infections “feed” off of the free iron ions in the bloodstream, including bacteria causing pneumonia. However, a hormone exclusively synthesized by the liver, hepcidin, has the unique ability of “hiding” iron from bacteria, limiting their spread throughout the human body.

Hepcidin is responsible for controlling iron metabolism: absorption, recycling, and utilization, and scientists from the University of Virginia (UVA) are quickly realizing that because of its unique role, hepcidin could be used to overcome many of the roadblocks put in place by bacterial resistance to antibiotics. "The rate at which these organisms become resistant to antibiotics is far faster than the rate at which we come up with new antibiotics. It's a race, and they're winning it," explained UVA’s Borna Mehrad, MBBS. Doctors are concerned in their anticipation for the day when there are no effective antibiotics left to treat a patient with bacterial pneumonia.

The power of hepcidin could be particularly life-saving for liver disease patients or people with genetic diseases like hereditary hemochromatosis who are especially vulnerable to bacterial pneumonia and other infections due to their lack of adequate hepcidin. In hereditary hemochromatosis, the body absorbs too much iron from the diet; excess iron stored in tissues and organs like the skin, heart, liver, pancreas, and joints; excess iron damages these tissues and organs, causing fatigue, joint pain, abdominal pain, and loss of sex drive.

Mehrad and a team of researchers from UVA tested hepcidin’s potential in mice studies, where the mice were genetically altered to lack hepcidin. As expected, these mice were extremely susceptible to infection when exposed to bacterial pneumonia; the connection between lacking hepcidin and being prone to infection is expected to be mirrored in humans.

Borna Mehrad, MBBS (left), and Kathryn Michels, both of the University of Virginia School of Medicine, have identified a hormone that helps the body fight off the spread of bacterial pneumonia. The discovery may offer a simple way to help vulnerable patients. Credit: Josh Barney | UVA Health System

There exists, in fact, a drug that closely resembles hepcidin; it decreases the iron levels in the blood. While being careful to avoid anemia, this drug could be applied to temporarily treat bacterial pneumonia in patients with liver disease or another hepcidin-limiting condition. Soon, another version of the drug could be developed based on the UVA research to increase hepcidin in the blood to treat bacterial infections.

The present study was published in the journal JCI Insight.

Sources: The Clinical Biochemist Reviews, Genetics Home Reference, American Lung Association, JCI Insight, University of Virginia Health System

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 25, 2019
Drug Discovery & Development
OCT 25, 2019
Novel Therapeutic For Eradicating The Flu Virus
Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading...
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti...
DEC 31, 2019
Genetics & Genomics
DEC 31, 2019
Should the Scientist Behind World's First Gene Edited Babies be in Prison?
He Jiankui, the scientist behind the world’s first gene-edited babies in 2018, has been sentenced to three years in prison by Chinese authorities for...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
Loading Comments...